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Abstract 
The pertinence of exploiting carbon fibre tow as an electrochemical sensing 
matrix for assessing pyocyanin production is evaluated. Pyocyanin is released by 
Ps. aeruginosa as a quorum signalling molecule during wound colonisation, 
increasing virulence and damaging host physiology, both contributing to an 
increased risk of infection. Prototype sensor assemblies have been developed 
and response characteristics towards pyocyanin are detailed. Sensitive and 
precise electrochemical measurements of pyocyanin by square wave 
voltammetry are established that enable the periodic monitoring of wound 
exudates for the presence of pyocyanin and serve as an early/pre- infection 
marker. As such, the pyocyanin sensor is presented as a possible sensor for 
intelligent wound management though incorporation into a 'smart-bandage' 
assembly or for use as a Point of Care Test for detection of Ps aeruginosa in 
cystic fibrosis patients' sputa. 
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Introduction 
The risk of hospital acquired (nosocomial) infections is relentless within modern 
healthcare. Whilst there are a multitude of factors that can give rise to infection -
in most cases however - the causative organisms are adventitious bacteria such 
as Pseudomonas aeruginosa, Staphylococcus aureus or Clostridium difficile 
[Mousa 1997, Chai et al 2000 and Vidhani et al 2001]. These have a direct 
impact on patient morbidity and mortality [Tredget et al 2004] and the associated 
complications that arise are estimated to increase the length of hospitalisation by 
between 6 and 13 days [Plowman 2000 and Fisher 1994]. Additionally, this 
incurs a substantial cost to healthcare, with a cost to the UK NHS alone in the 
billion pound region [Plowman 2003]. Whilst patient care guidelines from bodies 
such as the World Health Organisation (WHO) and the Health Protection Agency 
(HPA) are important, technology also has a part to play and recent advances in 
nano-particle science have seen the development of antibacterial dressings, 
frequently silver based [Atiyeh et al 2007]. Nevertheless, the innate adaptability 
of bacteria to rapidly mutate and generate resistant strains signifies the need for 
failsafe systems to identify the advent of a potential infection. 
The opportunistic pathogen Ps. aeruginosa is the cause of a variety of infections, 
with compromised patients being particularly susceptible targets. Amongst the 
most widespread of which are pulmonary infection in cystic fibrosis patients and 
wound infections. Infection of burns wounds are a particular problem, due to their 
physiology, increasing both morbidity and mortality [Tredget et al 2004]. This 
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coupled with the high incidence of antibiotic-resistant Ps. aeruginosa strains 
[Pirnay et al 2003, Cardo et al 2004] prompts the necessity to develop new 
antibiotic strategies. The ability to detect a Ps. aeruginosa infection early could 
not only improve patient morbidity and mortality, but reduce the time spent in 
hospital, reduce patients' pharmaceutical requirements and help curtail the 
financial burden of wound infections. 
Ps. aeruginosa uses many complex quorum sensing (communication) systems: 
regulatory mechanisms enabling bacteria to make collective decisions with 
respect to the expression of a specific gene set [Rasmussen and Givskov 2006] 
controlling virulence. Quorum sensing systems function through the release of 
sensing molecules, including: elastase, alkaline phosphatase, exotoxin A, 
secretion proteins, catalase, rhamnolipid, lectins, acylated homoserine lactones, 
superoxide dismutase and pyocyanin. [Smith and Iglewski 2003]. The quorum 
sensing components have been found to directly effect the virulence [Smith and 
Iglewski 2003] and the host's response to the infection. Pyocyanin (1-hydroxy-A/-
methylphenazine) is a blue redox-active phenazine dye synthesized de-novo by 
96-98% of Pseudomonas aeruginosa strains [Reyes et al 1982] as part of the 
quorum sensing systems. Due to the low molecular weight of pyocyanin [Watson 
et al 1986], it is readily diffusible and can permeate cell membranes. Upon entry 
into cells pyocyanin is reduced by NAD(P)H and may subsequently reduce 
molecular oxygen to superoxide, which in turn dismutates to hydrogen peroxide, 
4 
thereby inducing oxidative stress in endothelial and epithelial cells. [Muller 2006, 
Muller 2002, O'Malley et al 2004] 
The direct physiological effects on both epithelial and endothelial mammalian 
cells are of importance not only for its virulence determination within the Ps 
aeruginosa quorum sensing systems, but also for the direct affects (oxidative or 
not) on human physiology which may allow more serious infections to initiate. 
The physiological effects facilitating the progression of infection include: 
disruption of ciliary beating [Kanthankumar et al 1993], arresting cell growth and 
inducing apoptosis [Muller 2006], antioxidant depletion and oxidative stress 
[Muller 2002, O'Malley et al 2004, Lau et al 2004], acceleration of neutrophils 
apoptosis and reduced inflammatory response [Usher et al 2002] and bacterial 
resistance to innate immune system [Schaber et al 2004]. Pyocyanin acts 
antimicrobially towards other bacteria by oxidative means, (e.g. against E. coli), 
whereas Ps. aeruginosa itself appears immune to the oxidative effects of the 
pyocyanin by having limited redox-cycling [Hassett et al 1992]. 
Whilst it is impossible to establish a reference range for pyocyanin production 
through Ps. aeruginosa infection, the concentration range of 0-100|j,M has been 
investigated as this covers the concentrations liable to be encountered [Muller 
2006, Muller 2002, O'Malley et al 2004] and the diagnostically relevant range that 
has been observed in biofluids [Wilson et al 1988]. 
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The foundations of the pyocyanin sensor reported here rely upon the properties 
of carbon fibre tow allowing use as combined detection element and transduction 
conduit. 
The challenge and objective of the current investigation is the development of a 
sensor suitable for the detection of pyocyanin within biofluids, relevant to a 
variety of biomedical applications. Whilst the rudimentary detection of pyocyanin 
in biofluids has been studied at Hanging Mercury Drop Electrodes (HMDEs) 
[Vukomanovic et al 1996] its detection in wound fluid at solid electrodes within a 
Point of Care Testing format has yet to be considered. A principal application of a 
miniaturised pyocyanin sensor would be in the form of a 'smart-bandage' to allow 
intelligent in-situ wound monitoring. The periodical in-situ analysis of wound 
exudates would allow the early detection of pyocyanin production thereby alerting 
the patient or clinical staff to the likelihood of progression from contamination to 
colonisation. It would also allow early instigation of antibiotic therapies as the 
infection initiates and this may be prior to the appearance of an infection. 
The core rationale is outlined in Figure 1 whereby the carbon fibre tow is 
thermally sandwiched between polyester laminate, as detailed in previous 
publications [Sharp and Davis 2008x2]. The underlying carbon is selectively 




Materials & Methods: All reagents were of the highest grade available and used 
without further purification unless otherwise stated. All analytical solutions were 
prepared using Britton-Robinson buffer (acetic, boric and phosphoric acids -
each at a concentration of 0.04 M) in deionised water (Elgastat, Elga UK) 
adjusted to pH 7.0 (accumet® AP72, Fisher scientific) through the addition of 
sodium hydroxide (Sigma-Aldrich). Where required, samples were bubbled with 
oxygen-free nitrogen (BOC gases) for 5 minutes to remove oxygen or spiked with 
folic acid / folate (Sigma-Aldrich) prior to analysis. 
Pyocyanin synthesis and purification: Pyocyanin synthesis was performed by 
the photochemical degradation of 0.5g/L phenazine methosulfate, PMS, (Sigma-
Aldrich) [as used by Knight et al 1979] in Britton-Robinson buffer (pH 7.0). The 
synthesis was performed in a photochemical reactor (Figure 2) consisting of 8m 
of HPLC grade 1.5mm I.D. clear tubing wound around a commercially available 
aluminium fluorescent light fitting (Kengo lighting TCF13, 13Wlamp) and 
wrapped in tin foil to increase light-PMS interaction, PMS solution was circulated 
for 6 hours at 5 mL/min using a peristaltic pump (Gilson MINIPULS3). This 
yielded a strong blue coloured solution, from which the crude pyocyanin was 
extracted in three volumes of chloroform (Fisher Scientific), dried with 
magnesium sulphate (Fisher Scientific) and filtered (Whatman No. 42) prior to 
rotor-evaporation, in a 70°C waterbath, under vacuum onto chromatography 
silica gel (40-63u 60A FLUOROCHEM). The crude pyocyanin could then be 
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purified by column chromatography in a 50 x 5cm column using 15:85 methanol: 
chloroform, collecting only the blue portion and rotary-evaporated to dryness 
under vacuum. Purity was then ascertained by silica TLC plates (Rf 55-63 
crescent using eluent), melting point determination (MP=135°C) (stuart® SMP10) 
and NMR. The novel use of this photochemical reactor setup facilitated ~40% 
yield in 6 hours, allowing the synthesis and purification within a single working 
day. 
Sensor Construction: Laminated carbon fibre tow electrodes were prepared by 
thermally sandwiching Carbon Fibre tow, 2000x 10 \im diameter filaments 
(Goodfellow, UK) between 75|j,m thick sleeves of laser-etched (FB400 series 
CadCam Technology Ltd, Nottingham, UK) lamination pouch (Rexel UK) using a 
commercially available laminator. Electrical connection to the carbon tow was 
made through the presence of a strip of 100|j,m thick, adhesive-backed copper 
shielding tape (RS electronics). The electrodes were baked in a 100°C oven for 
16 hours to ensure the complete permeation of the resin between the fibres 
within the laminate. This is necessary to ensure the mechanical integrity and 
coherence of the seal between the sensing fibre layer and the insulating 
polyester sheath such that no solvent creep or de-lamination wound occur during 
extended monitoring periods (e.g. 20 scans over 40 minutes). Sensor 
anodisation was performed in 0.1M NaOH (Sigma) at +2.0Vfor 10 minutes. 
Instrumentation: Electrochemical measurements were conducted using 
nAutolab type III computer controlled potentiostat (Eco-Chemie, Utrecht, The 
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Netherlands) using a three electrode configuration consisting of a Glassy Carbon 
Electrode (3mm diameter; BAS Technicol. UK) or Carbon Fibre tow laminate 
working electrode, a 3M KCI Ag|AgCI half cell reference electrode (BAS 
Technicol. UK) and platinum wire counter electrode. Photometric measurements 
were performed using a JENWAY 6715 UV/Vis. spectrophotometer at 690nm. 
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Results and Discussion 
To allow the development of pyocyanin detection strategies the availability of 
pyocyanin is essential. The limited commercial availability of pyocyanin and high 
associated cost has lead to the purification or synthesis of pyocyanin by other 
means. Whilst pyocyanin has been extracted from bacterial cultures [Watson 
1986, Cox 1986, Hassett et al 1992, Frank and DeMoss 1959] the low yield and 
extensive extraction steps required to remove all other bacterial metabolites are 
unfavourable. The most commonly used, photochemical oxidation of phenazine 
methosulfate (PMS), originated by Mcllwain in 1937 [Mcllwain 1937], consisted of 
an open flask of PMS in water (1g/L) exposed to sunlight until no further 
pyocyanin was produced, typically 'about 1 day'. A latter optimised version of this 
method used illumination by high intensity cool white fluorescent lights for 4 days 
at a PMS starting concentration of 0.5g/L (Knight et al 1979) and has been 
favoured since [Usher et al 2002]. The main disadvantage of both methods, but 
more so of the revised method, is the prolonged illumination period. Not only 
does this prevent rapid and upon-demand synthesis of pyocyanin, but the 
synthesised pyocyanin in solution may degrade to 1-hydroxyphenazine [Mcllwain 
1937] affectively decreasing the efficiency. Increasing the photochemical reaction 
efficacy by using a photochemical reactor, as described within, allows a dramatic 
reduction in the duration of the photo-oxidation step allowing synthesis and 
purification within a single working day. 
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The preliminary assessment of carbon fibre substrates enabled comparison with 
the commonly used glassy carbon electrode voltammetry (Figure 3). Additionally, 
Figure 3, facilitated the comparison of plain (un-modified) and anodised 
(modified) carbon fibre tow, anodised 
Figure 3. Comparison of electrochemical detection 
of Pyocyanin by square voltammetry using GCE, 
plain and anodised carbon fibre sensors 
0 4 
o.o 
substrate has proven more adept 
to the quantification of certain 1° 
8 
biomarkers e.g. urate [Sharp and 
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Davis 2008]. The anodised tow has |
 4 
u 
a substantially greater response at 
0 
lower concentrations, due to the 
anodic fracturing previously 
observed following anodisation: increasing electron transfer kinetics due to the 
presence of more edge plan sites and greater concentration of oxygen species 
[Tao et al 2007]. As observed when using the glassy carbon electrode, the 
response is clearly non-linear as a result of the modifications and is saturated at 
much lower concentration than those required to be quantified in a biomedical 
scenario, as outlined in the introduction and is therefore unsuitable. 
20 40 60 80 
Pyocyanin concentration / uM 
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Figure 4. Square wave volammograms detailing 





Potential / V 
Plain carbon fibre tow does provide a 
linear response up to 100|j,M and was thus 
subject to further evaluation. Square wave 
voltammetry using plain carbon fibre tow 
gave rise to a single sharp oxidation peak 
observed at -0.17V which is attributed 
solely to the oxidation of pyocyanin 
(Figure 4). The scan range used (-0.4V to 
+0.1 V) was chosen specifically to prevent the polymerisation of pyocyanin onto 
the electrode at higher potentials as illustrated by cyclic voltammetry (Figure 5). 
The phenolic oxidation of pyocyanin (I) at +0.85V is responsible for the 
polymerisation of pyocyanin. The increase in pyocyanin oxidation and reduction 
peaks with increasing scans is the Figure 5. Cyclic voltammograms of pyocyanin after 0, 10, 20 and 30 scans. 
result of 2 electron transfer between 
the two polymeric forms (II) and (III) 
at -0.18V and -0.25V, respectively, 
with increasing scans. 
C C n -2e 
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Calibrations were performed in triplicate using a wide range of pyocyanin 
standards (1-100|j,M), to ensure accuracy and precision across the necessary 
biomedically important range. The designed electrode composition enabled linear 
quantification from 1|j,M to 100|j,M in buffered solutions (peak height/|jA = 
0.0814[Pyocyanin cone. I\M] -0.015, n=9, R2=0.998) indicating suitability for the 
proposed applications. The limit of detection of 0.030|j,M (LOD=3s/b) is beneficial 
to biomedical applications as sensitive detection of pyocyanin would enable the 
early detection of quorum sensing production of pyocyanin, by colonising Ps. 
aeruginosa. The earlier an infection can be diagnosed and treated leads to 
improved recovery rates and reduced chance of resistant strains of Ps. 
aeruginosa emerging. Furthermore, whilst relatively high concentrations of 
pyocyanin can be observed visually, by the strong blue colour of the pyocyanin 
pigment, this may be masked by the presence of blood in e.g. wound exudates 
and concentrations below 10|j,M appear colourless to the eye and subjective. 
This sensor would be able to detect at such low concentrations. 
Given that the sensor can clearly detect pyocyanin, a subsequent issue to be 
addressed relates to whether the sensor can reliably measure the pyocyanin 
concentration beyond the first three measurements used for calibration and 
assessment of linearity. Whilst this may not be an issue for certain applications 
e.g. single scan outpatient detection of pyocyanin in sputa of cystic fibrosis 
patients, it is for the applications where continuous sampling is required. The use 
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of a pyocyanin sensor within a wound environment would require periodic 
scanning to allow the early detection of pyocyanin. Two concentrations (10 and 
50|j,M) were used for intra-batch precision assessment, through 20 periodic 
replicates. The pyocyanin oxidation results in clearly visible, sharp peaks (Figure 
6 inlay) with no drift in oxidation potential with increasing replicates. 
120 
80 
After the requisite equilibration / 
preactivation scans (not shown), 
100 
the height of each pyocyanin ^ 
oxidation peak is presented as 
a percentage change from the 
D 40 
mean (Figure 6). The 
coefficient of variance for the 
10|j,M and 50|j,M populations 
Figure 6. Pyocyanin inter-batch precision over 20 replicates 
at 10|xM and 50|xM. Inlay: Example square wave 
voltammograms at both concentrations 
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are 1.2% and 1.4% respectively, with no deviation greater than 2.6% for either 
concentration, thus showing the narrow distribution of oxidation peaks. The 
graphical representation highlights the absence of substantial changes or 
obvious trends in oxidation peak height, effectively showing the absence of 
pyocyanin polymerisation or electrode fouling by oxidised pyocyanin metabolites. 
Due to the potential variety of biomedical applications for this novel pyocyanin 
sensor and the facultative anaerobe nature of Ps. aeruginosa it is important 
ensure the measurement is not affected by the presence or absence of molecular 
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oxygen. The measurement of a series of standards in triplicate performed both 
normally aerated and following bubbling with oxygen-free nitrogen gas, lead to 
the formation of two linear (Oxygen present: Peak height/|jA = 0.0764[Pyocyanin 
conc./nM] + 0.0378, n=7, R2=0.999 and oxygen absent: Peak height l\iA = 
0.0779[Pyocyanin cone./^M] + 0.0961, n=7, R2= 0.998) calibration plots. Whilst 
these are important as separate entities, the comparison of the two shows 
minimal difference between aerobic and anaerobic electrochemical detection of 
pyocyanin, again indicating suitability for use in a variety of applications. 
The negative potentials and narrow scan range utilised for the quantification of 
pyocyanin limits the potentially interfering Figure 7. Square wave voltammograms detailing 
the affects of 1 (xM and 10|xM folate additions on 
pyocyanin oxidation. 
endogenous molecules. Folate is the 
only biomarker considered electro-
active within this potential range at an 
appreciable concentration in biofluids, 
(reference range of up to 0.045|j,M in 
adult serum [Burtis et al 2006]) 
No folate 
1uM folate 
10 uM folate 
-0.3 0.0 o 1 -0.2 -0.1 
Potential / V 
therefore this was the only analyte deemed necessary to investigate for 
interference. Figure 7 shows that even greater folate concentrations have no 
observable effect on the pyocyanin oxidation peak of a 10|j,M pyocyanin standard, 
even at equimolar concentrations (over 200x the top of the adult folate reference 
range). The applicability of a sensitive pyocyanin sensor is not limited to that of a 
'smart-bandage' within a biomedical context. Pyocyanin concentrations within 
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cystic fibrosis (CF) patients' sputa have been detected as high as 130 |j,M 
[Wilson et al 1988]. The aforementioned affects on neutrophil apoptosis may be 
a clinically important mechanism of persistent infections by Ps aeruginosa in 
human tissue (e.g. chronic infections in CF patients) [Usher et al 2002]. Due to 
the potential severity and associated problems of Ps. aeruginosa infection within 
CF patients, a point of care testing (POCT) device enabling self/home monitoring 
of pyocyanin within the patient sputa could enable early detection of lung 
colonisation and by enabling earlier treatment of the patient during the infection 
may help the patients outcome and survival. An important factor to consider 
regarding pyocyanin as an infection biomarker is that pyocyanin is released prior 
to virulent colonisation, consequently it may be possible to detect the progression 
towards infection before a clinical infection is apparent. 
Conclusions 
The assessment of carbon fibre tow for the suitability of pyocyanin detection has 
allowed the interference free, sensitive and precise detection of pyocyanin at 
biologically relevant concentration. The sensor detailed within is thus deemed as 
potentially suitable for encompassment into a 'smart-bandage' to allow the early 
detection of Ps. aeruginosa colonisation of wounds. The sensor is also 
suggested as a potential Point of Care Test for the early detection and monitoring 
of pulmonary infections in cystic fibrosis patients. 
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Figure 1. (A) Schematic of the lamination process 
Figure 2. Photochemical reactor setup used for enhanced efficiency Phenazine Methosulfate photo-
oxidation to Pyocyanin 
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